Cover Image
Market Research Report

Global Cardiac Markers Market 2015-2019

Published by TechNavio (Infiniti Research Ltd.) Product code 222971
Published Content info 64 Pages
Immediate Delivery Available
Price
Back to Top
Global Cardiac Markers Market 2015-2019
Published: August 26, 2015 Content info: 64 Pages
Description

About cardiac markers

Cardiac markers are used for risk stratification and diagnosis of patients with suspected acute coronary syndrome and chest pain. Cardiac marker imaging is an effective, less expensive, and simple technique that helps a physician to decide whether the patient needs an invasive or complicated procedure. The cardiac marker testing is widely used in many medical settings especially for patients at low risk for cardiac death and patients with arteriosclerosis, conjunctive heart failure, sudden cardiac arrest, and myocardial infraction.

The various types of cardiac markers are:

  • Troponin test
  • Creatine Kinase test
  • Lactate dehydrogenase
  • Aspartate transaminase
  • Myoglobin
  • Ischemia-modified albumin
  • Pro-brain natriuretic peptide
  • Glycogen phosphorylase isoenzyme BB

The other cardiac markers are C-reactive protein, homocysteine, pulmonary embolism (D-dimer test), and high-density and low-density lipoproteins.

Technavio's analysts forecast the global cardiac markers market to grow at a CAGR of 9.64% during 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the global cardiac markers market for 2015-2019. The market can be divided into the following segments:

  • By diagnosis facility: POC testing and laboratory testing
  • By assay type: Troponin I and BNP

Technavio's report, Global Cardiac Markers Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Abbott
  • Alere
  • Roche Diagnostics
  • Siemens Healthcare

Other Prominent Vendors

  • AniBiotech
  • Axis-Shield
  • Beckman Coulter
  • Becton, Dickinson and Company
  • BG Medicine
  • Biomerieux
  • Boston Scientific
  • Critical Diagnostics
  • diaDexus
  • LifeSign
  • Mitsubishi Chemical Europe
  • Nanomix
  • Radiometer Medical
  • Randox Laboratories
  • Response Biomedical
  • Sierra Resources International
  • Singulex
  • Thermo Fisher Scientific
  • Trinity Biotech

Key market driver

  • Early diagnosis and preventive medicine
  • For a full, detailed list, view our report

Key market challenge

  • Lack of specific actions for detection of cardiac disorders
  • For a full, detailed list, view our report

Key market trend

  • Increased usage of POC diagnostic tests
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Table of Contents
Product Code: IRTNTR6898

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Cardiac markers overview

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by assay type

  • Global troponin I market
  • Global BNP market

PART 08: Market segmentation by diagnostic facility

  • Global cardiac POC testing market
  • Global cardiac laboratory testing market

PART 09: Geographical segmentation

  • Geographical segmentation of global cardiac markers market
  • Cardiac markers market in Americas
  • Cardiac markers market in EMEA
  • Cardiac markers market in APAC

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 16: Key vendor analysis

  • Abbott Diagnostics
  • Alere
  • Roche Diagnostics
  • Siemens Healthcare

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Cardiac marker tests and their respective cost savings
  • Exhibit 03: Characteristics of cardiac markers
  • Exhibit 04: Segmentation of global cardiac markers market by disease applications 2014
  • Exhibit 05: Global cardiac markers market segmentation
  • Exhibit 06: Global cardiac markers market 2014-2019 ($ billions)
  • Exhibit 07: Five forces analysis
  • Exhibit 08: Segmentation of global cardiac markers market by assay type
  • Exhibit 09: Segmentation of global cardiac markers market by assay type 2014
  • Exhibit 10: Segmentation of global cardiac markers market by assay type 2019
  • Exhibit 11: Segmentation of global cardiac markers market by assay type 2014-2019
  • Exhibit 12: Global troponin I market 2014-2019 ($ billions)
  • Exhibit 13: Global BNP market 2014-2019 ($ millions)
  • Exhibit 14: Segmentation of global cardiac markers market by diagnostic facility
  • Exhibit 15: Segmentation of global cardiac markers market by diagnosis facility 2014
  • Exhibit 16: Segmentation of global cardiac markers market by diagnostic facility 2019
  • Exhibit 17: Segmentation of global cardiac markers market by diagnostic facility 2014-2019
  • Exhibit 18: Global cardiac POC testing market 2014-2019 ($ millions)
  • Exhibit 19: Segmentation of global cardiac POC testing market by assay type
  • Exhibit 20: Global troponin I market in POC setting 2014-2019 ($ millions)
  • Exhibit 21: Global BNP market in POC setting 2014-2019 ($ millions)
  • Exhibit 22: Segmentation of global cardiac POC testing market by geography 2014
  • Exhibit 23: Global cardiac laboratory testing market 2014-2019 ($ billions)
  • Exhibit 24: Segmentation of global cardiac laboratory testing market by assay type
  • Exhibit 25: Global troponin I market in laboratory setting 2014-2019 ($ millions)
  • Exhibit 26: Global BNP market in laboratory setting 2014-2019 ($ millions)
  • Exhibit 27: Segmentation of global cardiac laboratory testing market by geography 2014
  • Exhibit 28: Segmentation of global cardiac markers market by geography 2014
  • Exhibit 29: Segmentation of global cardiac markers market by geography 2019
  • Exhibit 30: Segmentation of global cardiac markers market by geography 2014-2019
  • Exhibit 31: Cardiac markers market in Americas 2014-2019 ($ billions)
  • Exhibit 32: Cardiac markers market in EMEA 2014-2019 ($ millions)
  • Exhibit 33: Cardiac markers market in APAC 2014-2019 ($ millions)
  • Exhibit 34: Impact of drivers
  • Exhibit 35: Impact of drivers and challenges
  • Exhibit 36: Abbott: Key takeaways
  • Exhibit 37: Alere: Key takeaways
  • Exhibit 38: Roche Diagnostics: Key takeaways
  • Exhibit 39: Siemens Healthcare: Key takeaways
  • Exhibit 40: Abbott Diagnostics: Key business offerings
  • Exhibit 41: Alere: Business segmentation by revenue 2014
  • Exhibit 42: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 43: Alere: Geographical segmentation by revenue 2013 and 2014 ($ millions)
Back to Top